- STAT+: Cambrian’s experimental longevity drug mimics exerciseWhat Soon-Shiong has delivered, Encanta's RSV antiviral, and other biotech news from The ReadoutSTAT · 1mo ago↗ source
- Biogen adds more immune drugs in $1B buyout of secretive startup RayTheraThe companies didn’t specify the drugs Biogen is acquiring in the deal, though patents RayThera secured provide important clues.BioPharma Dive · 1mo ago↗ source
- IRA's Medicare out-of-pocket cap increased access to drugs, study findsMedication usage, particularly for the most expensive drugs, increased significantly shortly after the Medicare annual out-of-pocket cost cap took effect in January 2025, a study published in JAMA…Endpoints · 1mo ago↗ source